The Structure of Staphylococcus Aureus Explained

Staphylococcus aureus is a roughly spherical bacterium, about one micrometer across, whose layered architecture is central to its survival and its ability to cause disease. As a Gram-positive organism, it carries a thick cell wall loaded with peptidoglycan, but the full picture is more elaborate than that label suggests. From its golden-pigmented membrane to its surface-anchored adhesins and pore-forming toxins, almost every structural feature of S. aureus has a direct role in infection, immune evasion, or antibiotic resistance.

A Thick Peptidoglycan Shell

The most defining structural feature of S. aureus is the peptidoglycan layer that surrounds the cell. Peptidoglycan is a mesh-like polymer made of sugar chains cross-linked by short peptide bridges. What makes S. aureus peptidoglycan distinctive is the way those cross-links are built. Instead of the direct peptide bonds found in many other bacteria, S. aureus uses a chain of five glycine residues, called a pentaglycine interpeptide bridge, to connect neighboring sugar strands. Three enzymes, FemX, FemA, and FemB, assemble this bridge one glycine at a time using a specific amino acid carrier molecule.¹

Measurements using solid-state nuclear magnetic resonance show that these five-glycine bridges are not floppy or disordered. They adopt a compact shape with spacing similar to that of a tightly wound protein helix, and roughly three-quarters of all peptide stems in the wall are cross-linked this way.² That high degree of cross-linking is part of why S. aureus has such a rigid, mechanically tough shell. It also turns out to be the direct target of several antibiotics and the structural detail that MRSA strains have learned to work around, as we’ll see later.

Teichoic Acids Woven into the Wall

Threading through the peptidoglycan are long, negatively charged polymers called teichoic acids. S. aureus makes two types. Wall teichoic acid (WTA) is covalently attached to the peptidoglycan itself, while lipoteichoic acid (LTA) is anchored into the cell membrane below.³ Together, these two polymer systems play roles in maintaining cell shape, regulating how enzymes interact with the wall, and helping the bacterium divide properly.

WTA in S. aureus is built from repeating ribitol phosphate units decorated with sugar groups. One well-studied modification is the addition of a sugar called N-acetylglucosamine (GlcNAc) to the ribitol backbone, catalyzed by the enzyme TarM.⁴ These sugar decorations are not just cosmetic. They serve as recognition tags for the immune system and for bacteriophages, viruses that infect bacteria. Variation in WTA sugar patterns across different S. aureus strains shapes which phages can attach to which strains, with significant consequences for how genes (including resistance genes) move between bacterial populations.⁵

How Surface Proteins Are Anchored

Dotting the outside of the cell wall are dozens of different proteins, many of them virulence factors that help S. aureus invade tissues, evade the immune system, or grab nutrients. Getting these proteins stuck onto the wall requires a dedicated enzyme called sortase. Sortase recognizes a short amino acid sequence, abbreviated LPXTG, near the end of each surface protein. It cuts the protein at this site and then chemically links the newly exposed end directly to the peptidoglycan.⁶ The reaction depends on a single critical cysteine residue at position 184 of sortase; swapping that residue for alanine kills the enzyme’s activity entirely.⁷

Mutants that lack functional sortase cannot display surface proteins properly and are significantly less able to cause infections in animal models.⁸ This makes sortase an attractive drug target. An inhibitor that blocks it would strip S. aureus of its surface toolkit without directly killing the bacterium, potentially reducing the selection pressure that drives resistance.

Adhesins That Grab Host Tissues

Among the most important sortase-anchored proteins are the MSCRAMMs, short for microbial surface components recognizing adhesive matrix molecules. These are a family of proteins defined by the presence of two adjacent domains that fold in a manner similar to immunoglobulin (antibody) structures. MSCRAMMs bind to host molecules like fibrinogen and collagen through mechanisms that involve dramatic shape changes in the protein, such as the “dock, lock, and latch” sequence used to grip fibrinogen.⁹

Crystal structures of clumping factor A (ClfA), a key fibrinogen-binding MSCRAMM, reveal a fold now called the DEv-IgG fold, a variant of the classic immunoglobulin motif. ClfA uses two of these domains to create a groove between them where the tail end of the fibrinogen molecule docks.¹⁰ More recent work has identified a second binding site for fibrinogen on the top of one of the ClfA subdomains, meaning the protein grips its target at two separate points for a tighter hold.¹¹ ClfA is both a vaccine candidate and the target of monoclonal antibodies currently being evaluated in clinical trials.

The Polysaccharide Capsule

Many clinical isolates of S. aureus wrap themselves in an additional sugar coat outside the cell wall: the capsular polysaccharide (CPS). Two serotypes, types 5 and 8, account for the vast majority of encapsulated strains in human infections. These capsules are built from repeating trisaccharide units and are covalently linked back to the peptidoglycan underneath.¹² The capsule’s main job is to shield surface structures from recognition by immune cells, making it harder for white blood cells to engulf the bacterium.

The type 8 capsule, for instance, is composed of repeating units containing a modified sugar called N-acetylmannosaminuronic acid alongside two fucosamine sugars.¹³ Researchers have been trying for years to develop vaccines based on synthetic versions of these sugar chains. Getting the length and chemistry right turns out to matter enormously for triggering a useful immune response, and early vaccine candidates based on incomplete structural data struggled in clinical trials. Revised structures published after careful re-analysis of the polysaccharides have improved the prospects for next-generation vaccine design.¹²

The Golden Membrane

Beneath the cell wall sits the cytoplasmic membrane, a lipid bilayer that serves as the cell’s true boundary. S. aureus membranes contain an unusual pigment called staphyloxanthin, which gives colonies their characteristic golden color and lends the species its name (aureus means “golden” in Latin). Staphyloxanthin is not just decorative. Its rigid molecular backbone inserts into the membrane and tightens the lipid packing, reducing membrane fluidity and making the cell more resistant to attack by host immune molecules that try to punch holes in bacterial membranes.¹⁴

Biophysical studies have teased apart exactly how staphyloxanthin achieves this. It reduces the spacing between lipid headgroups and slows the movement of molecules within the membrane’s interior, but it does so without changing the shape of the fatty acid chains themselves. In other words, it stiffens the membrane through an unusual physical mechanism that decouples properties normally linked together.¹⁵ When staphyloxanthin production is blocked experimentally, MRSA cells become more fluid and more vulnerable to membrane-targeting antibiotics like polymyxin B.¹⁶ Drugs that target the pigment biosynthesis pathway are being explored as a way to weaken S. aureus without directly selecting for classical antibiotic resistance.

How S. aureus Divides

Because S. aureus is a coccus (a sphere), it does not elongate before dividing the way rod-shaped bacteria do. Instead, it builds a new wall across the middle of the cell, pinching itself in two. This process relies on a ring of the protein FtsZ that assembles at mid-cell and constricts inward, along with regulatory proteins like GpsB that form their own ring structures and help coordinate where and when new wall material is laid down.¹⁷

Once division is complete, the two daughter cells are still cemented together by shared peptidoglycan. Splitting them apart requires autolysins, enzymes that selectively chew through the wall at the division plane. The major autolysin in S. aureus, called Atl, carries two enzyme domains that cut different bonds in the peptidoglycan. One is an amidase that breaks the link between sugar chains and peptide stems; the other is a glucosaminidase that cuts within the sugar backbone itself. Deleting either domain leads to clusters of unseparated cells, and loss of the glucosaminidase causes cells to divide asymmetrically.¹⁸ These grape-like clusters, visible under a microscope, are the origin of the genus name Staphylococcus, from the Greek for “bunch of grapes.”

The Type VII Secretion System

S. aureus possesses a specialized protein export machine called the type VII secretion system (T7SS), encoded by a cluster of genes known as the ess locus. The central component is EssC, a large membrane-embedded motor protein that uses chemical energy to push virulence factors across the cell envelope and out of the cell.¹⁹ This system is activated by fatty acids found in host tissues, essentially switching on once the bacterium senses it is inside a living host.²⁰

Proper assembly of the T7SS depends on flotillin, a scaffold protein in the membrane. Without flotillin, the secretion machinery component EssB fails to form its normal clustered pattern in the membrane and instead spreads out diffusely, rendering the system nonfunctional.²¹ The T7SS is relatively recently discovered compared to secretion systems in Gram-negative bacteria, and its full list of secreted substrates is still being catalogued.

A Pore-Forming Toxin

One of the best-characterized structural products of S. aureus is alpha-hemolysin, a toxin that kills host cells by punching holes in their membranes. Alpha-hemolysin is secreted as individual water-soluble protein units that find a target cell membrane and then assemble into a ring of seven identical subunits. The resulting structure resembles a mushroom, with the cap sitting on the cell surface and a stem-like barrel penetrating through the membrane. The channel running through the center is about 100 angstroms long, narrowing to about 14 angstroms at its tightest point and widening to 46 angstroms at its broadest. Each subunit contributes two long strands to the 14-strand barrel that forms the transmembrane pore.²²

The elegance of this design is that the toxin is harmless while floating free as individual units. Assembly into the lethal pore only happens at the target membrane, making it a precisely controlled weapon. Alpha-hemolysin has become a model system for studying how proteins transition from soluble forms to membrane-inserted structures, and engineered versions of the pore are now used in nanopore DNA sequencing technology.

Biofilm as an Extended Structure

S. aureus does not always exist as free-floating single cells. On implanted medical devices, damaged heart valves, and chronic wounds, it commonly forms biofilms: dense communities of cells encased in a self-produced matrix. The biofilm matrix in S. aureus is a composite material made of polysaccharides (often called PIA, for polysaccharide intercellular adhesin), proteins, and extracellular DNA.²³

The extracellular DNA comes from a fraction of cells in the community that lyse, releasing their cytoplasmic contents. Those released proteins and DNA are then repurposed as structural glue that binds the surviving cells into large clusters.²⁴ This sacrifice-and-reuse strategy means the biofilm is partly built from the corpses of community members, a grimly efficient form of construction. Biofilms are a major clinical headache because the matrix physically blocks antibiotics and immune cells from reaching the bacteria inside, often necessitating surgical removal of infected devices.

Membrane Vesicles

S. aureus also releases small bubble-like structures called membrane vesicles (MVs) into its surroundings. These are pinched-off portions of the cell membrane, roughly 20 to 300 nanometers across, that carry a cargo of membrane proteins, cytoplasmic proteins, lipoteichoic acid, and even some capsular polysaccharide. Proteomic analysis shows that membrane-associated proteins and LTA are most strongly enriched in vesicles, while cell-wall-anchored proteins are largely excluded. Interestingly, the proteins packaged into MVs tend to have a higher positive charge than those left behind, suggesting that charge-based sorting plays a role in loading.²⁵

Vesicles give S. aureus a way to deliver toxins and immune-modulating molecules to distant host cells without the bacterium needing to be in direct contact. They are increasingly recognized as an important part of how S. aureus communicates with its environment and manipulates host defenses.

Why MRSA Is Structurally Different

Methicillin-resistant S. aureus (MRSA) owes its resistance to a structural change in the machinery that builds the cell wall. Normally, S. aureus uses enzymes called penicillin-binding proteins (PBPs) to cross-link new peptidoglycan. Beta-lactam antibiotics like methicillin work by locking up these PBPs so no new cross-links can form, which weakens the wall until the cell bursts. MRSA strains carry an extra gene, mecA, that encodes a replacement enzyme called PBP2a. PBP2a has a low affinity for beta-lactam antibiotics, allowing it to keep cross-linking peptidoglycan even when the normal PBPs are blocked.²⁶

The crystal structure of PBP2a reveals why antibiotics have trouble binding it. The enzyme’s active site, where cross-linking happens, is held in a closed conformation that excludes most incoming molecules. It only opens when a peptidoglycan building block binds to a separate allosteric site elsewhere on the protein, triggering a cascade of shape changes that make the active site accessible.²⁷ Beta-lactam antibiotics cannot trigger this opening efficiently, so they are left knocking on a door that barely opens. Understanding this gating mechanism has guided the design of newer antibiotics, like ceftaroline, that can bind the allosteric site and then access the active site, overcoming PBP2a-mediated resistance.

When Phages Exploit the Surface

Bacteriophages that infect S. aureus must first recognize and latch onto the cell’s surface structures, and wall teichoic acid is the most common receptor. The baseplate of phage 80α, for example, carries trimeric receptor-binding proteins whose platform domains attach specifically to the GlcNAc sugar decorations on WTA.²⁸ For the broad-host-range phage phi812, the architecture is even more elaborate: its baseplate arms carry two distinct receptor-binding proteins (RBP1 and RBP2) alongside tripod structures, with the WTA backbone serving as the primary attachment point and GlcNAc acting as a co-receptor.²⁹

This dependence on WTA means that S. aureus strains can evolve phage resistance by altering their teichoic acid modifications, but at a cost: those same modifications matter for normal cell function and immune evasion. Phage therapy against S. aureus, which is gaining interest as antibiotic resistance worsens, depends heavily on understanding exactly how phage recognition hardware interfaces with the bacterium’s surface chemistry.

L-Forms and the Limits of Structure

Under certain laboratory conditions, S. aureus can be coaxed into an unusual state called an L-form, in which the cell wall is largely or entirely absent. L-form colonies have a distinctive “fried-egg” appearance under the microscope, and the cells take on wildly variable shapes, stain as Gram-negative despite being genetically Gram-positive, and are generally fragile.³⁰ L-forms survive only in osmotically protected environments, but they are not merely a lab curiosity. There is growing interest in whether wall-deficient variants might persist inside host cells during chronic or relapsing infections, hidden from antibiotics that target cell wall synthesis. If true, the structural identity of S. aureus becomes something the organism can temporarily shed and later rebuild, a form of structural plasticity that complicates treatment strategies.